Replies to post #24768 on Mymetics Corp (MYMX)

[Work Harder]

The patent application for TL-532 and a new family of TLR3 ligands was filed by TOLLYS in 2018 (EP 18305561).

Don't find that one quickly

https://tollys.fr/intellectual-property/

18305561 in the U.S.

https://uspto.report/patent/app/20200080084

So it Vincent is getting another tranche from Bpifrance in June for human trials in late 2021 / early 2022

Then

we can speculate that the Catalent / Mymetics patent pending may hinge on the same type of funding from another

No Nih Hiv update last week but it do look like the Mymx insiders are ready to let someone else in

on positive results from Baylor / Bern / Hzi for covid alone

Is Ronnie a closer ?